ESR1 and breast cancer: To elucidate whether such DNA damage can disrupt ERα signaling and to determine the duration of such alterations, an in-depth analysis of estrogen signaling and the responsiveness to hormone therapy in 5-FU-treated breast cancer cells was conducted.